BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33865336)

  • 1. Correlation between quantitative perfusion histogram parameters of DCE-MRI and PTEN, P-Akt and m-TOR in different pathological types of lung cancer.
    Zhang B; Zhao Z; Huang Y; Mao H; Zou M; Wang C; Yu G; Zhang M
    BMC Med Imaging; 2021 Apr; 21(1):73. PubMed ID: 33865336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of MRI quantitative perfusion parameters with EGFR, VEGF and EGFR gene mutations in non-small cell cancer.
    Zou M; Zhang B; Shi L; Mao H; Huang Y; Zhao Z
    Sci Rep; 2024 Feb; 14(1):4447. PubMed ID: 38396128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between DCE-MRI quantitative perfusion histogram parameters, apparent diffusion coefficient and Ki-67 in different pathological types of lung cancer].
    Huang YN; Zhao ZH; Mao HJ; Yang JF; Wang T; Zhao L; Yang LM; Yu GM; Wang C
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(21):1645-1650. PubMed ID: 31189264
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor vascularity and glucose metabolism correlated in adenocarcinoma, but not in squamous cell carcinoma of the lung.
    Zhang J; Chen L; Chen Y; Wang W; Cheng L; Zhou X; Wang J
    PLoS One; 2014; 9(3):e91649. PubMed ID: 24614132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
    Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
    J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
    Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
    Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
    Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
    Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.
    Chen YL; Li R; Chen TW; Ou J; Zhang XM; Chen F; Wu L; Jiang Y; Laws M; Shah K; Joseph B; Hu J
    Eur J Radiol; 2019 Mar; 112():112-120. PubMed ID: 30777199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histogram Analysis of ADC Maps for Differentiating Brain Metastases From Different Histological Types of Lung Cancers.
    Bozdağ M; Er A; Çinkooğlu A
    Can Assoc Radiol J; 2021 May; 72(2):271-278. PubMed ID: 32602365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced MRI perfusion parameters are imaging biomarkers for angiogenesis in lung cancer.
    Du Y; Zhang S; Liang T; Shang J; Guo C; Lian J; Gong H; Yang J; Niu G
    Acta Radiol; 2023 Feb; 64(2):572-580. PubMed ID: 35369721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the mammalian target of rapamycin pathway markers in lung adenocarcinoma and squamous cell carcinoma.
    Kim HS; Kim GY; Lim SJ; Kim YW
    Pathobiology; 2012; 79(2):84-93. PubMed ID: 22286903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mTOR signalling cascade.
    Ma Z; Ma Y; Feng J; Xu Z; Cheng C; Qin J; Li S; Jiang J; Kong R
    Toxicol Appl Pharmacol; 2024 Apr; 485():116915. PubMed ID: 38537875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Dynamic Contrast-Enhanced MRI Parameters for Differentiating Squamous Cell Carcinoma and Malignant Lymphoma of the Oropharynx.
    Park M; Kim J; Choi YS; Lee SK; Koh YW; Kim SH; Choi EC
    AJR Am J Roentgenol; 2016 Feb; 206(2):401-7. PubMed ID: 26797371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.
    Sun K; Zhu H; Chai W; Zhan Y; Nickel D; Grimm R; Fu C; Yan F
    Eur Radiol; 2020 Jan; 30(1):57-65. PubMed ID: 31372782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between DCE-MRI Perfusion Histogram Parameters and EGFR and VEGF Expressions in Different Lauren Classifications of Advanced Gastric Cancer.
    Li Z; Zhao Z; Wang C; Wang D; Mao H; Liu F; Yang Y; Tao F; Lu Z
    Pathol Oncol Res; 2021; 27():1610001. PubMed ID: 35069035
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary lesions: correlative study of dynamic triple-phase enhanced CT perfusion imaging with tumor angiogenesis and vascular endothelial growth factor expression.
    Zou M; Zhao Z; Zhang B; Mao H; Huang Y; Wang C
    BMC Med Imaging; 2021 Oct; 21(1):158. PubMed ID: 34717573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.
    Zhang Y; Li Z; Gao C; Shen J; Chen M; Liu Y; Cao Z; Pang P; Cui F; Xu M
    Cancer Med; 2021 Jul; 10(13):4240-4249. PubMed ID: 34117733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging to predict extramural venous invasion in rectal cancer.
    Wang KX; Yu J; Xu Q
    BMC Med Imaging; 2023 Jun; 23(1):77. PubMed ID: 37291527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.
    Wu G; Huang W; Xu J; Li W; Wu Y; Yang Q; Liu K; Zhu M; Balasubramanian PS; Li M
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1771-1780. PubMed ID: 34398299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.